Tech Company Financing Transactions
valenTx Funding Round
valenTx closed a $22 million Series B funding round on 9/8/2009. Backers included Affinity Capital, EDF Ventures and Kaiser Permanente Ventures.
Transaction Overview
Company Name
Announced On
9/8/2009
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series B
Investors
EDF Ventures (Mary Lincoln Campbell)
SV Health Investors (Paul LaViolette)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6901 East Fish Lake Rd. 118
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
valenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jon St. Germain
Chief Medical Officer
Daniel Smith
VP - Regulatory Affairs
Allen Putnam
Browse more venture capital transactions:
Prev: 9/8/2009: VitalTrax venture capital transaction
Next: 9/8/2009: PlumChoice venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs